NCT00986362View on ClinicalTrials.gov

Clinical Trial of Intravitreal Microplasmin in Infants and Children Scheduled for Vitrectomy

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

December 31, 2011

Study Completion Date

April 30, 2012

Conditions
Vitrectomy
Interventions
DRUG

Ocriplasmin

175µg ocriplasmin intravitreal injection

DRUG

Placebo

Placebo intravitreal injection

Trial Locations (1)

48073

Associated Retina Consultants, Royal Oak

Sponsors

Lead Sponsor

ThromboGenics
All Listed Sponsors
lead

ThromboGenics

INDUSTRY

NCT00986362 - Clinical Trial of Intravitreal Microplasmin in Infants and Children Scheduled for Vitrectomy | Biotech Hunter | Biotech Hunter